Mount Hagen, as a vital hub in the Western Highlands of Papua New Guinea, is increasingly seeking advanced biochemical solutions to support its emerging agricultural and specialized healthcare sectors. Our factory brings 250,000sqm of production capacity to this market, adhering to cGMP standards.
Globally, the amino acid industry is shifting from bulk commodity production to high-purity chiral amino acids and protected derivatives. Our technical roadmap involves integrating AI-driven synthesis monitoring to ensure 99.9% purity levels, crucial for clinical-grade applications.
Q: How do you support the Mount Hagen local market?
A: We provide localized technical support and customized supply chain logistics tailored for the unique infrastructure of the Highlands.
Q: What is your quality control standard?
A: We operate under international cGMP guidelines, providing full documentation for every batch shipped.
